|
1
|
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ,
Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et
al: Heart disease and stroke statistics-2011 update: A report from
the American heart association. Circulation. 123:e18–e209. 2011.
View Article : Google Scholar
|
|
2
|
Forouzanfar MH, Moran AE, Flaxman AD, Roth
G, Mensah GA, Ezzati M, Naghavi M and Murray CJ: Assessing the
global burden of ischemic heart disease, part 2: analytic methods
and estimates of the global epidemiology of ischemic heart disease
in 2010. Glob Heart. 7:331–342. 2012. View Article : Google Scholar
|
|
3
|
Yu D, Li M, Tian Y, Liu J and Shang J:
Luteolin inhibits ROS-activated MAPK pathway in myocardial
ischemia/reperfusion injury. Life Sci. 122:15–25. 2015. View Article : Google Scholar
|
|
4
|
Chen C, Feng Y, Zou L, Wang L, Chen HH,
Cai JY, Xu JM, Sosnovik DE and Chao W: Role of extracellular RNA
and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.
J Am Heart Assoc. 3:e0006832014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanaka-Esposito C, Chen Q and Lesnefsky
EJ: Blockade of electron transport before ischemia protects
mitochondria and decreases myocardial injury during reperfusion in
aged rat hearts. Transl Res. 160:207–216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gustafsson AB and Gottlieb RA: Bcl-2
family members and apoptosis, taken to heart. Am J Physiol Cell
Physiol. 292:C45–C51. 2007. View Article : Google Scholar
|
|
7
|
Pfeffer MA and Braunwald E: Ventricular
remodeling after myocardial infarction. Experimental observations
and clinical implications. Circulation. 81:1161–1172. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop Dj and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Nbaheen M, Vishnubalaji R, Ali D,
Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M
and Aldahmash A: Human stromal (mesenchymal) stem cells from bone
marrow, adipose tissue and skin exhibit differences in molecular
phenotype and differentiation potential. Stem Cell Rev. 9:32–43.
2013. View Article : Google Scholar :
|
|
10
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jameel MN and Zhang J: Stem cell therapy
for ischemic heart disease. Antioxid Redox Signal. 13:1879–1897.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karpov AA, Uspenskaya YK, Minasian SM,
Puzanov MV, Dmitrieva RI, Bilibina AA, Anisimov SV and Galagudza
MM: The effect of bone marrow- and adipose tissue-derived
mesenchymal stem cell transplantation on myocardial remodelling in
the rat model of ischaemic heart failure. Int J Exp Pathol.
94:169–177. 2013.PubMed/NCBI
|
|
13
|
Janssens S, Dubois C, Bogaert J,
Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve
P, Dens J, et al: Autologous bone marrow-derived stem-cell transfer
in patients with ST-segment elevation myocardial infarction:
Double-blind, randomised controlled trial. Lancet. 367:113–121.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lunde K, Fjeld JG, Smith HJ, Solheim S,
Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A,
et al: Intracoronary injection of mononuclear bone marrow cells in
acute myocardial infarction. N Engl J Med. 355:1199–1209. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Orlic D, Kajstura J, Chimenti S, Jakoniuk
I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM,
et al: Bone marrow cells regenerate infarcted myocardium. Nature.
410:701–705. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murry CE, Soonpaa MH, Reinecke H, Nakajima
H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH,
Poppa V, et al: Haematopoietic stem cells do not transdifferentiate
into cardiac myocytes in myocardial infarcts. Nature. 428:664–668.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawada H, Fujita J, Kinjo K, Matsuzaki Y,
Tsuma M, Miyatake H, Muguruma Y, Tsuboi K, Itabashi Y, Ikeda Y, et
al: Nonhematopoietic mesenchymal stem cells can be mobilized and
differentiate into cardiomyocytes after myocardial infarction.
Blood. 104:3581–3587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spees JL, Olson SD, Whitney MJ and Prockop
DJ: Mitochondrial transfer between cells can rescue aerobic
respiration. Proc Natl Acad Sci USA. 103:1283–1288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Crevensten G, Walsh AJ, Ananthakrishnan D,
Page P, Wahba GM, Lotz JC and Berven S: Intervertebral disc cell
therapy for regeneration: Mesenchymal stem cell implantation in rat
intervertebral discs. Ann Biomed Eng. 32:430–434. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li B, Li R, Zhang C, Bian HJ, Wang F, Xiao
J, Liu SW, Yi W, Zhang MX, Wang SX, et al: MicroRNA-7a/b protects
against cardiac myocyte injury in ischemia/reperfusion by targeting
poly(ADP-ribose) polymerase. PLoS One. 9:e900962014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ekhterae D, Lin Z, Lundberg MS, Crow MT,
Brosius FC III and Núñez G: ARC inhibits cytochrome c release from
mitochondria and protects against hypoxia-induced apoptosis in
heart-derived H9c2 cells. Circ Res. 85:e70–e77. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Z, Liu Y, Deng W, Dai J, Li F, Yuan
Y, Wu Q, Zhou H, Bian Z and Tang Q: Hesperetin attenuates
mitochondria-dependent apoptosis in lipopolysaccharide-induced H9C2
cardiomyocytes. Mol Med Rep. 9:1941–1946. 2014.PubMed/NCBI
|
|
23
|
Han H, Zhu J, Zhu Z, Ni J, Du R, Dai Y,
Chen Y, Wu Z, Lu L and Zhang R: p-Cresyl sulfate aggravates cardiac
dysfunction associated with chronic kidney disease by enhancing
apoptosis of cardiomyocytes. J Am Heart Assoc. 4:e0018522015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao X, Zhang H, Zhuang W, Yuan G, Sun T,
Jiang X, Zhou Z, Yuan H, Zhang Z and Dong H: PEDF and PEDF-derived
peptide 44mer protect cardiomyocytes against hypoxia-induced
apoptosis and necroptosis via anti-oxidative effect. Sci Rep.
4:56372014.PubMed/NCBI
|
|
25
|
Loor G, Kondapalli J, Iwase H, Chandel NS,
Waypa GB, Guzy RD, Vanden Hoek TL and Schumacker PT: Mitochondrial
oxidant stress triggers cell death in simulated
ischemia-reperfusion. Biochim Biophys Acta. 1813:1382–1394. 2011.
View Article : Google Scholar :
|
|
26
|
Galluzzi L, Kepp O, Trojel-Hansen C and
Kroemer G: Mitochondrial control of cellular life, stress and
death. Circ Res. 111:1198–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Plotnikov EY, Khryapenkova TG, Galkina SI,
Sukhikh GT and Zorov DB: Cytoplasm and organelle transfer between
mesenchymal multipotent stromal cells and renal tubular cells in
co-culture. Exp Cell Res. 316:2447–2455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu K, Ji K, Guo L, Wu W, Lu H, Shan P and
Yan C: Mesenchymal stem cells rescue injured endothelial cells in
an in vitro ischemia-reperfusion model via tunneling nanotube like
structure-mediated mitochondrial transfer. Microvasc Res. 92:10–18.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Cui J, Sun X and Zhang Y:
Tunneling-nanotube development in astrocytes depends on p53
activation. Cell Death Differ. 18:732–742. 2011. View Article : Google Scholar :
|
|
30
|
Pasquier J, Guerrouahen BS, Al Thawadi H,
Ghiabi P, Maleki M, Abu-Kaoud N, Jacob A, Mirshahi M, Galas L,
Rafii S, et al: Preferential transfer of mitochondria from
endothelial to cancer cells through tunneling nanotubes modulates
chemoresistance. J Transl Med. 11:942013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cselenyák A, Benko Z, Szepes M, Kiss L and
Lacza Z: Stem cell transplantation in an in vitro simulated
ischemia/reperfusion model. J Vis Exp. 57:e35752011.PubMed/NCBI
|
|
32
|
Rustom A, Saffrich R, Markovic I, Walther
P and Gerdes HH: Nanotubular highways for intercellular organelle
transport. Science. 303:1007–1010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lou E, Fujisawa S, Morozov A, Barlas A,
Romin Y, Dogan Y, Gholami S, Moreira AL, Manova-Todorova K and
Moore MA: Tunneling nanotubes provide a unique conduit for
intercellular transfer of cellular contents in human malignant
pleural mesothelioma. PLoS One. 7:e330932012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Plotnikov EY, Khryapenkova TG, Vasileva
AK, Marey MV, Galkina SI, Isaev NK, Sheval EV, Polyakov VY, Sukhikh
GT and Zorov DB: Cell-to-cell cross-talk between mesenchymal stem
cells and cardiomyocytes in co-culture. J Cell Mol Med.
12:1622–1631. 2008. View Article : Google Scholar
|
|
35
|
Coué M, Brenner SL, Spector I and Korn ED:
Inhibition of actin polymerization by latrunculin A. FEBS Lett.
213:316–318. 1987. View Article : Google Scholar : PubMed/NCBI
|
